Revenue segments as reported by the company.

Products

Premiums

Services

Net investment income

Revenue Segments

Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Benefit costs

Operating expenses

Goodwill impairment

Store impairments

Opioid litigation charges

Loss on assets held for sale

Restructuring charge

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

CVS Health

Aetna is an American managed health care company, which sells traditional and consumer directed health care insurance plans and related services, such as medical, pharmaceutical, dental, behavioral health, long-term care, and disability plans. Aetna is a member of the Fortune 500.

Aetna

CVS Pharmacy is a subsidiary of the American retail and health care company CVS Health, headquartered in Woonsocket, Rhode Island. It was also known as, and originally named the Consumer Value Store and was founded in Lowell, Massachusetts, in 1963. The chain was owned by its original holding company Melville Corporation since its inception until its current parent company CVS Health was spun off into its own company in 1996. CVS Pharmacy is currently the largest pharmacy chain in the United States by number of locations (over 9,600 as of 2016) and total prescription revenue. As the retail pharmacy division of CVS Health, it ranks as the 7th largest U.S. corporation according to Fortune 500 in 2016. CVS Pharmacy's leading competitor Walgreens Boots Alliance ranked 37th.

CVS Pharmacy

CVS Health Corp. is a health solutions company, which engages in the provision of healthcare services. It operates through the following segments: Health Care Benefits, Health Services, Pharmacy and Consumer Wellness, and Corporate and Other. The Health Care Benefits segment operates as a health care benefits provider. The Health Services segment offers a full range of PBM solutions, delivers health care services in its medical clinics, virtually, and in the home. The Pharmacy & Consumer Wellness segment dispenses prescriptions in its retail pharmacies and through its infusion operations. The Corporate and Other Segment is involved in management and administrative expenses. The company was founded by Stanley P. Goldstein and Ralph Hoagland in 1963 and is headquartered in Woonsocket, RI.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

CVS Health exceeds Q4 expectations, eyes growth with Oak Street

CVS Health's strong financial performance in 2022, driven by revenue growth and exceeding EPS expectations, positions the company well for future growth.
The acquisition of Oak Street Health presents opportunities to expand into primary care and improve long-term earnings growth, despite challenges in maintaining retail performance.

CVS Health excels in Q1, eyes growth through acquisitions and innovation

CVS Health's strong financial performance, strategic acquisitions, and customer-centric initiatives position the company for sustained growth and competitive advantage.
While facing challenges in the evolving healthcare landscape, CVS Health's focus on innovation, affordability, and operational efficiency provides a solid foundation for future success.
By capitalizing on opportunities in growth, synergies, and healthcare services, CVS Health can navigate industry headwinds and drive long-term value creation for stakeholders.

CVS Health reports robust Q2 earnings, eyes growth opportunities

CVS Health's Q2 2023 performance reflects strong financial results and strategic acquisitions driving growth.
Despite challenges like higher costs and restructuring charges, the company remains confident in its ability to deliver outstanding performance.
Opportunities lie in expanding Medicaid contracts, biosimilar market establishment, and clinic openings for at-risk populations.
Overall, CVS Health's focus on cost optimization, digital sales growth, and patient engagement positions it well for future success.

CVS Health reports robust Q3 earnings and strategic growth plans

CVS Health's Q3 performance reflects strong financial results and strategic initiatives across its segments, positioning the company for sustainable growth.
While facing challenges like declining vaccine demand and contract losses, CVS Health is focused on leveraging opportunities in biosimilars and cost-saving solutions.
The company's commitment to operational excellence, innovation, and workforce investment underscores its strategic vision for becoming a leading health solutions provider.
With a clear focus on growth drivers and mitigating challenges, CVS Health is poised to capitalize on market opportunities and deliver value to shareholders.

CVS Health reports robust Q4 earnings, eyes Medicare margin recovery

CVS Health's Q4 2023 earnings call highlighted strong financial performance, a cautious stance on Medicare Advantage utilization, and a focus on transforming healthcare delivery. The company is committed to margin recovery, growth, and enhancing customer experience while addressing challenges in Medicare Advantage trends and cost pressures.

CVS Health faces Medicare Advantage challenges, focuses on margin improvement

CVS Health's Q1 2024 earnings call highlighted strong financial performance, challenges in the Medicare Advantage business, and a focus on improving margins. The company showcased strengths in the biosimilar market and Pharmacy & Consumer Wellness segment while addressing issues impacting Health Care Benefits and Services segments.

CVS Health's Q2 2024 performance reflects strong financial results, cost savings, and innovative initiatives in pharmacy services.
The company faces challenges in the Health Care Benefits segment but is actively addressing them through leadership changes and operational improvements.
Opportunities for growth include driving margin improvements, expanding digital reach, and educating stakeholders on the value delivery of PBMs.
Expectation of margin recovery in Medicare Advantage and double-digit EPS growth in 2025 highlight CVS Health's strategic focus on operational efficiencies and cost savings.

CVS Health reports robust Q3 earnings, focuses on growth strategies

CVS Health's Q3 2024 performance was marked by strong financial results, leadership changes, and segment-specific challenges and successes. The company is focused on leveraging opportunities in strategic initiatives and addressing areas for improvement to drive future growth.

Revenue

Cost of revenue

Gross profit

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

WOONSOCKET, R.I., April 12, 2021 /PRNewswire/ -- In an ongoing effort to expand access to COVID-19 vaccines and help the country move forward from the pandemic, CVS Health (NYSE: CVS) today announced that it will begin vaccinating eligible populations on Wednesday, April 14 at 10 select CVS Pharmacy locations in Maine.

CVS Health to Administer No-Cost COVID-19 Vaccines at 10 Select CVS Pharmacy Locations in Maine

WOONSOCKET, R.I., April 12, 2021 /PRNewswire/ -- In an ongoing effort to expand access to COVID-19 vaccines and help the country move forward from the pandemic, CVS Health (NYSE: CVS) today announced that it will begin vaccinating eligible populations on Wednesday, April 14 at 11 select CVS Pharmacy locations in Nebraska.

CVS Health to Administer No-Cost COVID-19 Vaccines at 11 Select CVS Pharmacy Locations in Nebraska

WOONSOCKET, R.I., April 8, 2021 /PRNewswire/ -- CVS Health (NYSE: CVS) today announced that MinuteClinic, the medical clinic inside CVS Pharmacy, is now offering Video Visits for patients in the state of Montana.

MinuteClinic Video Visit Telehealth Offering Now Available in Montana

CVS Health's (CVS) antibody test detects for previous infection to COVID-19 and provides results within 15 minutes.

CVS Health (CVS) Extends COVID-19 Antibody Testing Nationwide

CVS looks like good value here for most investors. CVS stock is worth at least 8% to 15.5% more at $80.34 to $85.82, based on value metrics and other analysts.

CVS Looks Like Good Value Here for Most Investors

CVS Health (CVS) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Why the Earnings Surprise Streak Could Continue for CVS Health (CVS)

WOONSOCKET, R.I., April 6, 2021 /PRNewswire/ -- CVS Health (NYSE: CVS) has surpassed $200 million in affordable housing investments in California as part of an ongoing commitment to address housing insecurity throughout the country.

CVS Health Affordable Housing Investments in California Surpass $200 Million

CVS has made several strategic moves to position the company to create value in the healthcare space. Patient shareholders will likely be rewarded by growing earnings over time.

Why CVS Stock Has Room for 25% Upside or More in 2021

Shares of CVS Health Corp. were down 0.1% in premarket trading on Monday after the pharmacy retail giant said it is now offering COVID-19 antibody tests at all 1,100 MinuteClinic locations in the U.S. except in Nevada. The tests, which can detect a previous infection with the virus, require a $38 upfront payment.

CVS to now offer COVID-19 antibody tests for $38

WOONSOCKET, R.I., April 5, 2021 /PRNewswire/ -- CVS Health (NYSE: CVS) today announced the availability of COVID-19 antibody testing at MinuteClinic locations across the country.

CVS Health Announces Availability of COVID-19 Antibody Testing at MinuteClinic Locations Across the Country

CVS Health (NYSE:CVS) is a health products retailer and integrated health care services provider. It is also a classic example of a financially robust giant trading at low valuations, in my opinion.

CVS Health: A Rare Underpriced Healthcare Blue-Chip

CVS Health: A Rare Underpriced Health Care Blue-Chip

Anthem

UnitedHealth Group

By Robert Ross Things are finally starting to calm down here in California. After a major surge in COVID-19 cases over the holidays, cases are back down to where they were in fall 2020: Source: The New York Times We have the successful vaccination rollout to thank for most of the decline.

These 3 Digital Care Stocks Aren't Going Anywhere but Up

CVS just surpassed 10 million COVID-19 vaccine doses given to people in the US. The company announced April 1 it had given more than 10 million vaccine shots in about 2,000 stores across 44 states, Puerto Rico, and Washington, DC.

CVS has given more than 10 million COVID-19 vaccine doses (CVS)

Shares of CVS Health Corp. are up 0.6% in premarket trading on Thursday after the pharmacy chain said it has administered more than 10 million doses of COVID-19 vaccines through its participation in two federal programs. One program focuses on vaccinating people in long-term care facilities, the other is community-focused.

CVS said it's administered more than 10 million COVID-19 vaccine doses

WOONSOCKET, R.I., April 1, 2021 /PRNewswire/ -- CVS Health (NYSE: CVS) has surpassed 10 million COVID-19 vaccine doses administered through its participation in the Pharmacy Partnership for Long-Term Care Program and Federal Retail Pharmacy Program.

CVS Health Surpasses 10 Million COVID-19 Vaccine Doses Administered

CVS Health said it will expand its Covid-19 vaccination efforts to nearly 2,000 U. S. drugstores in 44 states, Puerto Rico and Washington, D.

CVS Expands Covid-19 Vaccinations To Pharmacies In 44 States

CVS Health Corp. released its latest corporate social responsibility (CSR) report, Transform Health 2030, that includes goals for engagement with customers and patients, new environmental goals and the company's first standalone diversity report. CVS is launching a "go green" portal on its website to help customers find sustainable products and learn how to reduce waste and recycle.

CVS sets new environmental sustainability goals, releases first diversity report

WOONSOCKET, R.I., March 31, 2021 /PRNewswire/ -- CVS Health today announced new goals in support of its long-term corporate social responsibility (CSR) strategy, Transform Health 2030, and released its 14th annual CSR report.

CVS Health Announces Transform Health 2030 Goals, Releases 14th Annual Corporate Social Responsibility Report

In the latest trading session, CVS Health (CVS) closed at $76.08, marking a -0.29% move from the previous day.

CVS Health (CVS) Stock Moves -0.29%: What You Should Know

Amgen

Bayer AG

Cardinal Health

Gilead Sciences

General Mills

Henkel AG & Co KGaA

Novo Nordisk

Reckitt Benckiser Group PLC

Walgreens

In the following article, I present 10 recession-proof stocks that are undervalued right now. Including companies from the healthcare sector like Gilead Sciences, Amgen, Novo Nordisk, Walgreens Boots Alliance, CVS Health, Cardinal Health and Bayer.

Hunting For Recession-Proof Bargains: 10 Picks As Prey

CVS Health Corp. said Monday that it will start administering COVID-19 vaccinations in four additional states starting March 31. The new locations include five pharmacies in New Mexico; two each in West Virginia and Delaware; and six in Washington.

CVS to start administering COVID-19 vaccinations in 4 additional states on March 31

WOONSOCKET, R.I., March 29, 2021 /PRNewswire/ -- In an ongoing effort to expand access to COVID-19 vaccines and help the country move forward from the pandemic, CVS Health (NYSE: CVS) today announced that it will begin vaccinating eligible populations on Wednesday, March 31 at two select CVS Pharmacy locations in Delaware.

CVS Health to Administer No-Cost COVID-19 Vaccines at Select CVS Pharmacy Locations in Delaware

WOONSOCKET, R.I., March 29, 2021 /PRNewswire/ -- In an ongoing effort to expand access to COVID-19 vaccines and help the country move forward from the pandemic, CVS Health (NYSE: CVS) today announced that it will begin vaccinating eligible populations on Wednesday, March 31 at five select CVS Pharmacy locations in New Mexico.

CVS Health to Administer No-Cost COVID-19 Vaccines at Select CVS Pharmacy Locations in New Mexico

WOONSOCKET, R.I., March 29, 2021 /PRNewswire/ -- In an ongoing effort to expand access to COVID-19 vaccines and help the country move forward from the pandemic, CVS Health (NYSE: CVS) today announced that it will begin vaccinating eligible populations on Wednesday, March 31 at six select CVS Pharmacy locations in Washington.

News for CVS Health Stock (CVS)